SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Zonagen (zona) - good buy?

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: Richard Singer who wrote (603)9/30/1997 9:55:00 AM
From: Dauntless   of 7041
 
Thanks for the heads up on the pfizer presentation. I don't think it will have any additional effect - we know they filed - they HAD TO as they were on record as planning to file in the 3rd Qtr - companies like pfizer don't make promises & not deliver.

To the previous poster, it's pretty optimistic to expect approval by next spring. Remember, all pfizer did was file - approval is another mater & can't be predicted.

Do I wish Zona had filed first - of course. See Bruce's post as to why it's not a death blow. I'd expect the stock to take a hit for a few days but then recover as the good news continues. The institutional investors knew all about the pfizer submission several months ago - if it falls very far they'll be on it as a bargain. Remember, Zona has other prospects besides Vasomax.

Good Luck.
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext